Ignite Creation Date:
2025-12-24 @ 2:47 PM
Ignite Modification Date:
2026-01-31 @ 9:15 PM
Study NCT ID:
NCT06856759
Status:
RECRUITING
Last Update Posted:
2025-07-01
First Post:
2024-12-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Single-Dose AAV-MECP2 Safety/Tolerability and Efficacy in Rett Syndrome
Sponsor:
Guangzhou Women and Children's Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-01-14
Start Date Type:
ACTUAL
Primary Completion Date:
2029-10-23
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-10-23
Completion Date Type:
ESTIMATED
First Submit Date:
2024-12-29
First Submit QC Date:
None
Study First Post Date:
2025-03-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-27
Last Update Post Date:
2025-07-01
Last Update Post Date Type:
ACTUAL